Status:
UNKNOWN
Bioimpedance Evaluation of Therapeutic Titration in Essential, Refractory Hypertension
Lead Sponsor:
CardioDynamics
Conditions:
Hypertension
Eligibility:
All Genders
18+ years
Brief Summary
To determine whether impedance cardiography (ICG) parameters can predict favorable or unfavorable blood pressure (BP) response and time to BP control prior to initiation or intensification of specific...
Detailed Description
* Patients with higher vascular resistance index and/or lower arterial compliance index will lower BP faster and to a greater degree overall when receiving vasodilating agents - such as ACEI's, ARB's,...
Eligibility Criteria
Inclusion
- \> 18 years of age
- Able to provide written consent
- Meet JNC definition of hypertension
- Lab results with 6 months for: serum creatinine, urine albumin/creatinine ratio, and at least one of the following: serum glucose, or glycated hemoglobin, or hemoglobin A1C
Exclusion
- Active cardiovascular disease (unstable angina, stage C or D heart failure, uncontrolled superventricular arrhythmia, hx of ventricular arrhythmia, stroke or TIA within 6 months, ACS within 6 months)
- Implantation of activated ventricular pacemaker
- Known hypersensitivity or allergy to sensor gel or adhesives
- Skin lesions prohibiting sensor placement
Key Trial Info
Start Date :
January 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2011
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00913094
Start Date
January 1 2009
End Date
June 1 2011
Last Update
June 11 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wayne State University
Detroit, Michigan, United States, 48201